SleepRes Inc. received FDA 510(k) clearance for its Kricket Positive Airway Pressure device in December 2025, introducing a new approach to treating obstructive sleep apnea that could address one of CPAP therapy's biggest challenges: patient comfort.
The device, which will launch commercially in the first half of 2026, uses what the company calls Kairos technology to dynamically adjust air pressure throughout each breathing cycle—a significant departure from traditional CPAP machines that maintain constant, fixed pressure throughout the night.
How Kricket Differs From Traditional CPAP
Standard CPAP machines deliver a continuous stream of air at a prescribed pressure level, which can feel uncomfortable or unnatural to many patients. Some machines offer "auto-titrating" features that adjust pressure based on detected apnea events, but they still maintain relatively stable pressure within each breathing cycle.
The Kricket device takes a different approach. Rather than maintaining steady pressure, it adapts moment-to-moment as you breathe, aiming to better synchronize therapy with natural breathing patterns and airway changes. This dynamic adjustment reduces unnecessary pressure while still preventing airway collapse.
"The goal is to provide enough pressure to keep the airway open when it needs support, but to reduce pressure when it doesn't," explained a company representative familiar with the technology.
For patients who find traditional CPAP uncomfortable—particularly those who struggle with the sensation of breathing against constant pressure or who experience side effects like aerophagia (air swallowing), dry mouth, or nasal congestion—this adaptive approach could make therapy more tolerable.
Flexibility for Different Needs
Beyond its signature Kairos technology, the Kricket device also offers standard CPAP and automatic PAP modes as alternatives. This flexibility allows sleep physicians to customize treatment based on individual patient needs and preferences.
The device is approved for patients weighing more than 66 pounds and can be used at home, in hospitals, and in sleep centers, making it suitable for both initial diagnosis and long-term therapy.
Addressing the Adherence Crisis
The development of more comfortable CPAP alternatives comes at a critical time. Studies consistently show that approximately 50% of sleep apnea patients abandon CPAP therapy within the first year, primarily due to comfort issues.
This adherence crisis has serious health implications. Untreated obstructive sleep apnea significantly increases the risk of cardiovascular disease, stroke, diabetes, cognitive decline, and motor vehicle accidents. When patients can't tolerate the primary treatment, their health suffers.
David White, Chief Medical Officer of SleepRes and a professor at Harvard Medical School, has been a leading researcher in sleep medicine for decades. The company's focus on improving the patient experience reflects growing recognition that even the most effective therapy is worthless if patients won't use it.
Better technology means nothing if patients leave the mask on the nightstand. Comfort and tolerability are just as important as efficacy.
Scaling Up for Launch
SleepRes is currently scaling manufacturing capacity and establishing clinical partnerships and education programs ahead of the device's commercial launch. The company has not disclosed pricing, though industry observers expect it to be competitive with premium CPAP machines currently on the market.
The launch will position Kricket in an increasingly crowded field of CPAP alternatives. Recent developments include hypoglossal nerve stimulation implants like the Genio system, oral medications like AD109 nearing FDA approval, and evidence that GLP-1 drugs may reduce sleep apnea severity.
Who Might Benefit Most
The Kricket device may be particularly useful for:
- CPAP-intolerant patients who have tried traditional machines but couldn't adjust to the sensation of constant pressure
- Patients with pressure-related side effects such as aerophagia, sinus discomfort, or bloating
- New sleep apnea patients who want to start with the most comfortable PAP option available
- Those who travel frequently and want a more adaptable therapy that can adjust to different sleeping conditions
As with any medical device, the Kricket PAP requires a prescription and should be used under the guidance of a sleep specialist. Patients interested in trying the device should discuss it with their physician to determine if it's appropriate for their specific case.
The Future of PAP Therapy
The FDA clearance of Kricket represents a broader trend in sleep medicine: the recognition that one-size-fits-all approaches don't work for complex conditions like obstructive sleep apnea. As technology advances, treatment is becoming more personalized, more comfortable, and more responsive to individual patient needs.
For the millions of Americans who need positive airway pressure therapy but struggle with conventional CPAP machines, innovations like Kricket offer hope that effective treatment doesn't have to come at the cost of comfort and quality of life.
